Lomustine 40mg
| Product Overview | |
| Generic Name | Lomustine 40mg | 
| Brand Name(s) | Gleostine, CCNU, CeeNu, Ceenu, Lomuwin, Lomoother, Belustine | 
| Form | Oral hard gelatin capsules /100 Cap Package | 
| Strength | 40 mg | 
| Therapeutic Class | Alkylating agent (nitrosourea) | 
| ATC Code | L01AD02 | 
| Manufacturing & Regulatory | |
| Manufacturer | GSK, Chandra Bhagat, Samarth Life Sciences, TherDose, Intas, Saintroy, Ocean Pharma, Lexicare, PBP, Blue Earth, | 
| Country | USA, UK, India, Mexico | 
| GMP Compliance | ISO, cGMP, USFDA/EUGMP, WHO-GMP | 
| DMF/CEP | Type II | 
| COFEPRIS | Registered in Mexico | 
| Free Sale Certificate | Available per batch upon request | 
| Logistics & Export | |
| MOQ | 20 packs/boxes of 100 Caps | 
| Shelf Life | 24 Months | 
| Storage | Room temperature (15–30 °C) or cool and dry place | 
| Incoterms | EXW/FOB/CIF negotiable | 
| Lead Time | 7 to 10 Days | 
| Documentation | |
| Certificate of Analysis (COA) | Available from manufacturer/distributor | 
| SDS | Handling guidelines for cytotoxic alkylating agents available from suppliers | 
| CTD Summary | Not publicly available; may be provided by originator under NDA or with commercial engagement | 
Description
Indications & Usage: Lomustine is used orally to treat recurrent high-grade gliomas, Hodgkin’s lymphoma, melanoma, lung cancer, and other malignancies.
 
				